Literature DB >> 35657568

Evaluation of macular blood flow after intermittent intravenous infusion of high-dose corticosteroids (pulse therapy) in patients with thyroid-associated orbitopathy (TAO) using angio-OCT.

Nilay Yuksel1.   

Abstract

Entities:  

Year:  2022        PMID： 35657568     DOI： 10.1007/s00417-022-05714-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  Evaluation of subclinical alterations in retinal layers and microvascular structures with OCT and OCTA in healthy young short-term smokers.

Authors:  Mehmed Uğur Işik; Fahrettin Akay; Berkay Akmaz; Yusuf Ziya Güven; Ömer Faruk Şahin
Journal:  Photodiagnosis Photodyn Ther       Date:  2021-08-11       Impact factor: 3.631

2.  Retinal blood flow and vascular reactivity in chronic smokers.

Authors:  Kalpana Rose; John G Flanagan; Sunni R Patel; Richard Cheng; Christopher Hudson
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-06       Impact factor: 4.799

Review 3.  Thyroid hormones and cardiovascular disease.

Authors:  Avais Jabbar; Alessandro Pingitore; Simon H S Pearce; Azfar Zaman; Giorgio Iervasi; Salman Razvi
Journal:  Nat Rev Cardiol       Date:  2016-11-04       Impact factor: 32.419

4.  Effects of bisoprolol and cilazapril on the central retinal artery blood flow in patients with essential hypertension--preliminary results.

Authors:  Andrzej Madej; Stanisława Gierek-Ciaciura; Maciej Haberka; Joanna Lekston-Madej; Marcin Basiak; Olga Domańska; Bogusław Okopień
Journal:  Ups J Med Sci       Date:  2010-09-22       Impact factor: 2.384

5.  Evaluation of macular blood flow after intermittent intravenous infusion of high-dose corticosteroids (pulse therapy) in patients with thyroid-associated orbitopathy (TAO) using angio-OCT.

Authors:  Chiara Del Noce; Matilde Roda; Lorenzo Ferro Desideri; Carlo E Traverso; Aldo Vagge
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-09-01       Impact factor: 3.117
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.